C. Ward < C. Warren Olanow < C. Waterman

Facettes :

List of bibliographic references indexed by C. Warren Olanow

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]

Ident.	Authors (with country if any)	Title
000203 (2011)	C. Warren Olanow [États-Unis] ; K. Mcnaught [États-Unis]	Parkinson's disease, proteins, and prions: Milestones
000248 (2011)	C. Warren Olanow [États-Unis] ; Kathryn B. Wunderle [États-Unis] ; Karl Kieburtz [États-Unis]	Milestones in movement disorders clinical trials: Advances and landmark studies
000249 (2011)	Daniela Berg [Allemagne] ; Jonathan D. Steinberger [États-Unis] ; C. Warren Olanow [États-Unis] ; Thomas P. Naidich [États-Unis] ; Tarek A. Yousry [Royaume-Uni]	Milestones in magnetic resonance imaging and transcranial sonography of movement disorders
000337 (2011)	Thomas D. H Lbig [États-Unis, Allemagne] ; Stephanie Assuras [États-Unis] ; Judy Creighton [États-Unis] ; Joan C. Borod [États-Unis] ; Winona Tse [États-Unis] ; Pasquale G. Frisina [États-Unis] ; Andrei Voustianiouk [États-Unis] ; Jean-Michel Gracies [États-Unis] ; C. Warren Olanow [États-Unis]	Differential role of dopamine in emotional attention and memory: Evidence from Parkinson's disease
000385 (2011)	Raymond T. Bartus [États-Unis] ; Christopher D. Herzog [États-Unis] ; Yaping Chu [États-Unis] ; Alistair Wilson [États-Unis] ; Lamar Brown [États-Unis] ; Joao Siffert [États-Unis] ; Eugene M. Johnson Jr. [États-Unis] ; C. Warren Olanow [États-Unis] ; Elliott J. Mufson [États-Unis] ; Jeffrey H. Kordower [États-Unis]	Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains
000582 (2010)	Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni]	Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP‐treated common marmosets
000668 (2010)	Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis]	Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study
000757 (2010)	C. Warren Olanow [États-Unis, Italie] ; Karl Kieburtz [États-Unis]	Defining disease‐modifying therapies for PD—A road map for moving forward
000B09 (2009)	C. Warren Olanow [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; Anthony E. Lang [Canada] ; Jose A. Obeso [Espagne]	Dopaminergic transplantation for parkinson's disease: Current status and future prospects
000C20 (2008)	C. Warren Olanow [États-Unis] ; Karl Kieburtz [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni]	Why have we failed to achieve neuroprotection in Parkinson's disease?
000C36 (2008)	Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis]	Treatment of levodopa‐induced motor complications
000D61 (2008)	C. Warren Olanow [États-Unis]	Levodopa/dopamine replacement strategies in Parkinson's disease—Future directions
000E13 (2008)	Anthony H. V. Schapira [Royaume-Uni] ; C. Warren Olanow [États-Unis]	Drug selection and timing of initiation of treatment in early Parkinson's disease
000E78 (2008)	C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France]	A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
000F34 (2007)	C. Warren Olanow [États-Unis]	The pathogenesis of cell death in Parkinson's disease – 2007
001075 (2007)	Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]	Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
001170 (2006)	C. Warren Olanow [États-Unis] ; Kevin St. P. Mcnaught [États-Unis]	Ubiquitin–proteasome system and Parkinson's disease
001458 (2005)	C. Warren Olanow [États-Unis] ; Joseph Jankovic [États-Unis]	Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis‐targeted, disease‐modifying strategy
001571 (2004)	Kevin St. P. Mcnaught [États-Unis] ; Daniel P. Perl [États-Unis] ; Anna-Liisa Brownell [États-Unis] ; C. Warren Olanow [États-Unis]	Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
001613 (2004)	C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]	Levodopa in the treatment of Parkinson's disease: Current controversies
001648 (2004)	Matthew B. Stern [États-Unis] ; Kenneth L. Marek [États-Unis] ; Joseph Friedman [États-Unis] ; Robert A. Hauser [États-Unis] ; Peter A. Lewitt [États-Unis] ; Daniel Tarsy [États-Unis] ; C. Warren Olanow [États-Unis]	Double‐blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients

---

List of associated KwdEn.i

Nombre de documents	Descripteur
13	Parkinson's disease
4	levodopa
3	motor complications
2	dopamine agonists
2	dyskinesia
2	proteasome
2	rasagiline
2	α‐synuclein
1	Abbreviations: AIMS = Abnormal Involuntary Movements Scale; MPTP = 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine; UPDRS = Unified Parkinson’s Disease Rating Scale
1	Clinical trials
1	Delayed start study
1	Disease modification
1	Keywords: lisuride; Parkinson’s disease; randomized trial; prospective trial; dyskinesia
1	Long term simple study
1	L‐dopa
1	MPTP
1	PD
1	PD dementia
1	Prions
1	Proteins
1	advanced Parkinson's disease
1	alpha‐synuclein
1	application and limitation
1	axonal transport
1	basal ganglia
1	centrosome
1	delayed start design
1	diagnostic criteria
1	disease modification
1	dopamine
1	driving
1	dyskinesias
1	emotional processing
1	executive functions
1	familial Parkinson's disease
1	future perspectives
1	magnetic resonance imaging
1	memory
1	monoamine oxidase inhibitors
1	monotherapy
1	motor disability
1	motor fluctuations
1	movement disorders
1	neural repair
1	neurodegeneration
1	neuroprotection
1	neurotoxicity
1	neurotrophic factors
1	oxidative stress
1	pathogenesis
1	pramipexole
1	primate
1	protein accumulation
1	safety
1	sleep episode
1	somnolence
1	task force
1	tolerability
1	transcranial sonography
1	translational research
1	ubiquitin
1	ubiquitin‐proteasome system
1	γ‐tubulin

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "C. Warren Olanow" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "C. Warren Olanow" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    C. Warren Olanow
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024